New online program aims to ease breast cancer distress

NCT ID NCT07392424

Not yet recruiting Symptom relief Sponsor: Gabriela Ilie Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a 6-month online program for women with newly diagnosed breast cancer. The program includes daily exercise, mindfulness, and support via email and optional group sessions. Researchers want to see if it reduces psychological distress and improves well-being compared to standard care. 160 women in Nova Scotia will participate, with results measured at 6 and 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Breast Cancer Patient Empowerment Program (BreastCancerPEP) - a 6-month digital behavioral intervention with exercise, mindfulness, and support
What this could lead to: If it works, this could offer a simple, home-based way to improve mental and physical health for women undergoing breast cancer treatment.
What could go wrong: This is a small, early-stage trial (160 people) testing a behavioral program, not a drug. Results may not apply to all patients, and the program may not reduce distress significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Empowerment invasive breast carcinoma Patient Participation Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Queen Elizabeth II Health Sciences Centre

Halifax, Nova Scotia, B3H 1V7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.